Price (delayed)
$5.735
Market cap
$279.28M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$5.93
Enterprise value
$525.84M
uniQure is delivering on the promise of gene therapy - single treatments with potentially curative results. We are leveraging our modular and validated technology platform to rapidly advance a pipeline
There are no recent dividends present for QURE.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified. Data from and Sharadar.